Besides age, my understanding is it could also have something to do with the patients IPSS score which is broken into Low, Intermediate 1, Intermediate 2 and High. It is not the general treatment for MDS patients who fit into the Low and Intermediate 1 category, because their life expectancy out weighs the risks one takes with transplant. However, patients with Intermediate 2 and High have a lower life expectancy and therefore it is considered that the risks involved in transplant may give them a better prognosis.
Do you know what your husbands IPSS score is?
__________________
Sandi, partner of Paul 62, diagnosed MDS Intermediate 2; July 2012. Pancytopenia, Cytogenetics -7 +8 Chromosomes. Low Blast cell count. Currently on EPO & G-CSF and having great response. MUD found will be admitted to Royal Perth Hospital 27 March 2013 to start SCT process.
|